Your browser does not allow JavaScript!
JavaScript is necessary for the proper functioning of this website. Please enable JavaScript or use a modern browser.
Repository of the University of Ljubljana
Open Science Slovenia
Open Science
DiKUL
slv
|
eng
Search
Advanced
New in RUL
About RUL
In numbers
Help
Sign in
Details
Inflammatory landscape in Xeroderma pigmentosum patients with cutaneous melanoma
ID
Chikhaoui, Asma
(
Author
),
ID
Režen, Tadeja
(
Author
),
ID
Komel, Radovan
(
Author
),
ID
Yacoub-Youssef, Houda
(
Author
), et al.
PDF - Presentation file,
Download
(3,20 MB)
MD5: BADE9F89E3A3B764542B40329D2F5B85
URL - Source URL, Visit
https://www.nature.com/articles/s41598-022-17928-z
Image galllery
Abstract
Xeroderma pigmentosum (XP) is a DNA repair disease that predisposes to early skin cancers as cutaneous melanoma. Melanoma microenvironment contains inflammatory mediators, which would be interesting biomarkers for the prognosis or for the identification of novel therapeutic targets. We used a PCR array to evaluate the transcriptional pattern of 84 inflammatory genes in melanoma tumors obtained from XP patients (XP‑Mel) and in sporadic melanoma (SP‑Mel) compared to healthy skin. Commonly expressed inflammatory genes were further explored via GTEx and GEPIA databases. The differentially expressed inflammatory genes in XP were compared to their expression in skin exposed to UVs, and evaluated on the basis of the overall survival outcomes of patients with melanoma. Monocyte subsets of patients with SP‑Mel, XP and healthy donors were also assessed. PCR array data revealed that 34 inflammatory genes were under‑expressed in XP‑Mel compared to SP‑Mel. Differentially expressed genes that were common in XP‑Mel and SP‑Mel were correlated with the transcriptomic datasets from GEPIA and GTEx and highlighted the implication of KLK1 and IL8 in the tumorigenesis. We showed also that in XP‑Mel tumors, there was an overexpression of KLK6 and KLK10 genes, which seems to be associated with a bad survival rate. As for the innate immunity, we observed a decrease of intermediate monocytes in patients with SP‑Mel and in XP. We highlight an alteration in the immune response in XP patients. We identified candidate biomarkers involved in the tumorigenesis, and in the survival of patients with melanoma. Intermediate monocyte’s in patients at risk could be a prognostic biomarker for melanoma outcome.
Language:
English
Keywords:
xeroderma pigmentosum
,
cutaneous melanoma
,
inflammatory mediators
,
biomarkers
,
melanoma
,
monocytes and macrophages
,
nucleotide excision repair
Work type:
Article
Typology:
1.01 - Original Scientific Article
Organization:
MF - Faculty of Medicine
Publication status:
Published
Publication version:
Version of Record
Year:
2022
Number of pages:
13 str.
Numbering:
Vol. 12, art. 13854
PID:
20.500.12556/RUL-165904
UDC:
616-006
ISSN on article:
2045-2322
DOI:
10.1038/s41598-022-17928-z
COBISS.SI-ID:
121891075
Publication date in RUL:
13.12.2024
Views:
377
Downloads:
176
Metadata:
Cite this work
Plain text
BibTeX
EndNote XML
EndNote/Refer
RIS
ABNT
ACM Ref
AMA
APA
Chicago 17th Author-Date
Harvard
IEEE
ISO 690
MLA
Vancouver
:
Copy citation
Share:
Record is a part of a journal
Title:
Scientific reports
Shortened title:
Sci. rep.
Publisher:
Nature Publishing Group
ISSN:
2045-2322
COBISS.SI-ID:
18727432
Licences
License:
CC BY 4.0, Creative Commons Attribution 4.0 International
Link:
http://creativecommons.org/licenses/by/4.0/
Description:
This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Secondary language
Language:
Slovenian
Keywords:
xeroderma pigmentosum
,
kožni melanom
,
vnetni mediatorji
Projects
Funder:
Tunisia, Ministry of Public Health
Funder:
Tunisia, Ministry of Higher Education and Scientific Research
Project number:
LR16IPT05
Funder:
IPT
Funding programme:
Projet Collaborative Interne
Acronym:
PCI_Melanoma
Funder:
ARRS - Slovenian Research Agency
Project number:
P1-0104
Name:
Funkcijska genomika in biotehnologija za zdravje
Funder:
ARRS - Slovenian Research Agency
Project number:
P1-0390
Name:
Funkcijska genomika in biotehnologija za zdravje
Similar documents
Similar works from RUL:
Similar works from other Slovenian collections:
Back